Search

everythinglearnresearchcommunity

for

Search:↓

The treatment improved survival and controlled cancer spread but required managing side effects like rashes.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Targeted cancer therapies can cause skin side effects, but activating SOS in the skin may help reduce them.

Ginkgolide B and bilobalide help mink hair grow by making skin cells healthier and boosting a key growth protein.

The treatment was ineffective in humans.

New treatment with green tea polyphenols and nicotinamide improves skin problems from cancer therapy.

FOL-005 peptide may help treat excessive hair growth safely.

Nexin 1 may help control hair growth.

RNA aptamers can specifically block FGF5-related cell growth, potentially treating related diseases or hair disorders.

Tofacitinib may help treat nail dystrophy, especially when other treatments fail.

AP-1 controls tumor cell type by affecting key signaling pathways.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

ATP-sensitive K+ channel subunits, particularly Sur2A, play a significant role in various cancers.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Lack of KSR1 stops certain skin tumors in mice.

Targeted anticancer therapies often cause skin issues, affecting treatment adherence and quality of life.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

JAK inhibitors offer new hope for treating severe alopecia areata.

Baricitinib and tofacitinib have different safety patterns in treating alopecia areata.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Tyrosine kinase inhibitors show promise in treating some skin diseases but their definitive role in dermatology is still unclear.

Spironolactone may make some cancer treatments more effective by blocking a protein that helps cancer cells survive.

Oral baricitinib is effective and safe for treating alopecia areata.

Scaffold-based drug delivery systems improve oral cancer treatment by targeting drugs directly to cancer cells, reducing side effects.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

Tofacitinib is effective for severe alopecia areata, similar to oral betamethasone.

Certain compounds from Panax ginseng can block proteins that affect hair growth, potentially helping treat hair loss.